EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors

Yu-Huei Huang iD, Lun-Ching Chang iD, Ya-Ching Chang, Wen-Hung Chung, Shun-Fa Yang iD, Shih-Chi Su

International Journal of Molecular Sciences · 26.02.2023 · 24 (5) · 4568

DOI: 10.3390/ijms24054568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.02.2023. Verfasst von Yu-Huei Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Psoriasis, Biological Products. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Linkou Chang Gung Memorial Hospital, Ministry of Science and Technology of Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alterations in the gut microbiota composition and their associated metabolic dysfunction exist in psoriasis. However, the impact of biologics on shaping gut microbiota is not well known. This study aimed to determine the association of gut microorganisms and microbiome-encoded metabolic pathways with the treatment in patients with psoriasis. A total of 48 patients with psoriasis, including 30 cases who received an IL-23 inhibitor (guselkumab) and 18 cases who received an IL-17 inhibitor (secukinumab or ixekizumab) were recruited. Longitudinal profiles of the gut microbiome were conducted by using 16S rRNA gene sequencing. The gut microbial compositions dynamically changed in psoriatic patients during a 24-week treatment. The relative abundance of individual taxa altered differently between patients receiving the IL-23 inhibitor and those receiving the IL-17 inhibitor. Functional prediction of the gut microbiome revealed microbial genes related to metabolism involving the biosynthesis of antibiotics and amino acids were differentially enriched between responders and non-responders receiving IL-17 inhibitors, as the abundance of the taurine and hypotaurine pathway was found to be augmented in responders treated with the IL-23 inhibitor. Our analyses showed a longitudinal shift in the gut microbiota in psoriatic patients after treatment. These taxonomic signatures and functional alterations of the gut microbiome could serve as potential biomarkers for the response to biologics treatment in psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomePsoriasisBiological ProductsHumansInterleukin-17RNA, Ribosomal, 16SInterleukin-23

Stichwörter der Autor:innen

guselkumabgut microbiotainterleukin-17 inhibitorinterleukin-23 inhibitorixekizumabmetabolic pathwaypsoriasissecukinumab

Substanzen

Interleukin-17RNA, Ribosomal, 16SInterleukin-23Biological Products

Autor:innen und Institutionen

  • Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan.
  • Department of Dermatology, Chang Gung Memorial Hospital, Linkou Branch, Taoyuan 333, Taiwan.
  • School of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
  • Department of Mathematical Sciences, Florida Atlantic University, Boca Raton, FL 33431, USA.
  • Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung 204, Taiwan.
  • Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan.

ORCID-Profile: Yu-Huei Huang, Lun-Ching Chang, Shun-Fa Yang

Förderung

  • Ministry of Science and Technology
  • Linkou Chang Gung Memorial Hospital
  • Ministry of Science and Technology of Taiwan
  • Chang Gung Memorial Hospital

Zitieren

APA

Huang, Y. H., Chang, L. C., Chang, Y. C., Chung, W. H., Yang, S. F., & Su, S. C. (2023). Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors. International Journal of Molecular Sciences, 24(5), 4568. https://doi.org/10.3390/ijms24054568

Vancouver

Huang YH, Chang LC, Chang YC, Chung WH, Yang SF, Su SC. Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors. International Journal of Molecular Sciences. 2023;24(5):4568. doi:10.3390/ijms24054568

BibTeX
@article{Huang2023,
  author = {Huang, Yu-Huei and Chang, Lun-Ching and Chang, Ya-Ching and Chung, Wen-Hung and Yang, Shun-Fa and Su, Shih-Chi},
  title = {Compositional Alteration of Gut Microbiota in Psoriasis Treated with IL-23 and IL-17 Inhibitors},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {4568},
  doi = {10.3390/ijms24054568}
}
Kostenlos starten →